Compare ITUB & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITUB | MDT |
|---|---|---|
| Founded | 1924 | 1949 |
| Country | Brazil | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4B | 131.9B |
| IPO Year | 2002 | 2014 |
| Metric | ITUB | MDT |
|---|---|---|
| Price | $7.96 | $87.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 19 |
| Target Price | $9.00 | ★ $109.82 |
| AVG Volume (30 Days) | ★ 25.5M | 7.8M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | ★ 5.80% | 3.25% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | $46.74 | $8.91 |
| Revenue Next Year | $7.95 | $6.75 |
| P/E Ratio | ★ $12.60 | $31.72 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $5.12 | $79.55 |
| 52 Week High | $9.60 | $106.33 |
| Indicator | ITUB | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 22.17 |
| Support Level | $7.30 | $85.41 |
| Resistance Level | $8.00 | $88.52 |
| Average True Range (ATR) | 0.22 | 1.91 |
| MACD | -0.13 | -0.96 |
| Stochastic Oscillator | 1.07 | 2.20 |
Itau Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itau and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itau's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.